We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Yanks Notice of PDUFA Fee Increase for Fiscal 2022
FDA Yanks Notice of PDUFA Fee Increase for Fiscal 2022
The FDA has abruptly withdrawn a notice that was scheduled to be published in the Federal Register (FR) Tuesday, announcing a sharp increase in the fees for drugmakers under the Prescription Drug User Fee Act (PDUFA).